Education Center

Current Regimens and Guideline Implications for the Treatment of Actinic Keratosis: Proceedings of a Clinical Roundtable at the 2011 Winter Clinical Dermatology Conference

Supported by PharmaDerm, a division of Nycomed US, Inc.

 

 

 

Recommended for You

Expert Content

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Next Article: